CD44 and neoplasm: In the H441 model (Fig. 2A), there was a robust increase in CSC marker positive tumor cells with a ∼3-fold increase in CD44+ cells, a 12.5-fold increase in CD133+ cells and a 5-fold increase in CD117+ cells (Fig. 2A).